We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $22.1B
1-Year Est. Return 45.54%
This Fund
S&P 500
This Quarter Est. Return
+9.12%
1 Year Est. Return
+45.54%
3 Year Est. Return
+139.2%
5 Year Est. Return
+180.26%
10 Year Est. Return
AUM
$13.2B
AUM Growth
+$1.19B
Cap. Flow
+$398M
Cap. Flow %
3.01%
Top 10 Hldgs %
25.15%
Holding
2,888
New
90
Increased
233
Reduced
1,480
Closed
57

Top Sells

Rank Stock Value
1
EFA icon
iShares MSCI EAFE ETF
EFA
+$33.4M
2
AAPL icon
Apple
AAPL
+$20.4M
3
MSFT icon
Microsoft
MSFT
+$10.9M
4
TWTR
Twitter, Inc.
TWTR
+$9.15M
5
Y
Alleghany Corp
Y
+$7.32M

Sector Composition

Rank Sector Weight
1 Technology 19.64%
2 Healthcare 13.35%
3 Financials 12.18%
4 Consumer Discretionary 9.16%
5 Industrials 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVL icon
1476
Marvell Technology
MRVL
$199B
$650K ﹤0.01%
17,546
+84
+0.5% +$3.43K
ETWO
1477
DELISTED
E2open Parent Holdings
ETWO
$648K ﹤0.01%
110,394
CASH icon
1478
Pathward Financial
CASH
$1.78B
$647K ﹤0.01%
15,031
-1,474
-9% -$60.5K
MHO icon
1479
M/I Homes
MHO
$3.82B
$647K ﹤0.01%
14,005
-1,505
-10% -$64.6K
UNIT
1480
Uniti Group
UNIT
$2.31B
$646K ﹤0.01%
116,806
-6,634
-5% -$45.5K
BATRK icon
1481
Atlanta Braves Holdings Series B
BATRK
$3.41B
$644K ﹤0.01%
19,979
AVTA
1482
DELISTED
Avantax, Inc. Common Stock
AVTA
$643K ﹤0.01%
25,201
-1,690
-6% -$38.7K
SXI icon
1483
Standex International
SXI
$4B
$643K ﹤0.01%
6,276
-479
-7% -$47K
MED icon
1484
Medifast
MED
$130M
$642K ﹤0.01%
5,564
-529
-9% -$61.6K
CTS icon
1485
CTS Corp
CTS
$1.82B
$640K ﹤0.01%
16,241
-576
-3% -$23.7K
MRTN icon
1486
Marten Transport
MRTN
$1.22B
$640K ﹤0.01%
32,340
ENVA icon
1487
Enova International
ENVA
$6.52B
$638K ﹤0.01%
16,640
PAYO icon
1488
Payoneer
PAYO
$2.41B
$638K ﹤0.01%
116,622
SAFT icon
1489
Safety Insurance
SAFT
$1.52B
$637K ﹤0.01%
7,561
-486
-6% -$41.3K
CIM
1490
Chimera Investment
CIM
$993M
$636K ﹤0.01%
38,529
-3,197
-8% -$59.6K
ARES icon
1491
Ares Management
ARES
$32.1B
$635K ﹤0.01%
9,272
-139
-1% -$10K
HLIT icon
1492
Harmonic Inc
HLIT
$1.42B
$633K ﹤0.01%
48,325
SPHR icon
1493
Sphere Entertainment
SPHR
$6.33B
$630K ﹤0.01%
14,014
ONT
1494
Onterris Inc
ONT
$576M
$629K ﹤0.01%
14,169
+340
+2% +$14.4K
UPBD icon
1495
Upbound Group
UPBD
$1.15B
$626K ﹤0.01%
27,782
EIG icon
1496
Employers Holdings
EIG
$864M
$624K ﹤0.01%
14,459
CTKB icon
1497
Cytek Biosciences
CTKB
$636M
$623K ﹤0.01%
61,031
TFIN icon
1498
Triumph Financial Inc
TFIN
$1.87B
$623K ﹤0.01%
12,749
RNAM
1499
DELISTED
Avidity Biosciences
RNAM
$623K ﹤0.01%
28,077
+2,469
+10% +$36.8K
RELY icon
1500
Remitly
RELY
$5.39B
$622K ﹤0.01%
54,301

Similar funds

MetLife Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, MetLife Investment Management held 2,888 positions worth $13.2B, up 9.9% from $12B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

MetLife Investment Management deployed $398M of net new capital in Q4 2022, opening 90 new positions and adding to 233 existing holdings. Its largest new stake was Atlassian: 8,691 shares worth $1.12M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares MSCI EAFE ETF, an estimated $33.4M trimmed.

  • MetLife Investment Management's largest Q4 2022 buy was Atlassian: 8,691 shares worth $1.12M.
  • MetLife Investment Management added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2022, an estimated $651M increase.
  • MetLife Investment Management's biggest Q4 2022 reduction was iShares MSCI EAFE ETF, cutting an estimated $33.4M.
  • MetLife Investment Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $9.15M.
  • MetLife Investment Management's ten largest holdings make up 25% of its $13.2B portfolio in Q4 2022.
  • MetLife Investment Management opened 90 new positions and closed 57 in Q4 2022.
  • MetLife Investment Management's portfolio value rose 9.9% quarter-over-quarter to $13.2B.

Based on MetLife Investment Management's 13F filing for Q4 2022, filed 15 Feb 2023.